A Phase 1 Study of the Safety and Tolerability of ICM20 in Adults
- First Posted Date
- 2022-08-31
- Last Posted Date
- 2024-07-17
- Lead Sponsor
- IC-MedTech Corporation
- Target Recruit Count
- 13
- Registration Number
- NCT05523596
- Locations
- 🇺🇸
Culmore Clinic, Falls Church, Virginia, United States
🇺🇸Parkway Medical, Glen Burnie, Maryland, United States
🇺🇸Baylor College of Medicine, Houston, Texas, United States
Double-Blinded Clinical Trial Using Apatone®B for Symptomatic Postoperative Total Joint Replacements
Phase 2
Completed
- Conditions
- OsteolysisForeign Body ReactionEdematousSynovitis
- Interventions
- Drug: Apatone®BDrug: Placebo
- First Posted Date
- 2011-01-10
- Last Posted Date
- 2018-01-31
- Lead Sponsor
- IC-MedTech Corporation
- Target Recruit Count
- 57
- Registration Number
- NCT01272830
- Locations
- 🇺🇸
Summa Health System, Akron, Ohio, United States
© Copyright 2025. All Rights Reserved by MedPath